The Immune Landscape of Non–Small-Cell Lung Cancer. Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures-Reference-Cited by-同舟云学术

The Immune Landscape of Non–Small-Cell Lung Cancer. Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures

Published:2018-07 Issue:1 Volume:198 Page:24-38
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Beattie Jason¹,Yarmus Lonny²,Wahidi Momen³,Rivera M. Patricia⁴,Gilbert Christopher⁵,Maldonado Fabien⁶,Czarnecka Kasia⁷,Argento Angela⁸,Chen Alexander⁹,Herth Felix¹⁰,Sterman Daniel H.¹

Affiliation:

1. New York University Langone Health, New York University School of Medicine, New York, New York

2. Division of Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, Maryland

3. Division of Pulmonary and Critical Care, Duke University School of Medicine, Durham, North Carolina

4. Division of Pulmonary and Critical Care, University of North Carolina School of Medicine, Chapel Hill, North Carolina

5. Department of Thoracic Surgery, Swedish Medical Center, Seattle, Washington

6. Division of Pulmonary and Critical Care, Vanderbilt University School of Medicine, Nashville, Tennessee

7. Division of Pulmonary and Critical Care, University of Toronto School of Medicine, Toronto, Ontario, Canada

8. Division of Pulmonary and Critical Care, Northwestern University School of Medicine, Chicago, Illinois

9. Division of Pulmonary and Critical Care, Washington University of St. Louis School of Medicine, St. Louis, Missouri; and

10. Division of Pulmonary Medicine, Thoraxklinik at Heidelberg University, Heidelberg, Germany

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201712-2539PP

Reference151 articles.

1. AJRCCM: 100-YearAnniversary.The Shifting Landscape for Lung Cancer: Past, Present, and Future

2. Epidemiology of Lung Cancer

3. Global cancer statistics, 2012

4. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

5. Checkpoint Blockade in Lung Cancer and Mesothelioma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of Cytologic vs Histologic Specimens for Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer;CHEST;2023-09

2. Navigational bronchoscopy specimens and PD-L1 expression: a retrospective study;Journal of Thoracic Disease;2022-02

3. Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity;American Journal of Respiratory and Critical Care Medicine;2021-11-15

4. Identification of Immune Function-Related Subtypes in Cutaneous Melanoma;Life;2021-09-06

5. Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological Specimens;Chest;2021-08